NovaMin: likely clinical success.
Wefel
J S
JS
Department of Pediatric Dentistry and Dows Institute for Dental Research, College of Dentistry, University of Iowa, Iowa City, Iowa 52246, USA. James-wefel@uiowa.edu
D001031:Apatites / Q000008:administration & dosage / Q000627:therapeutic use; D002130:Calcium Phosphates / Q000008:administration & dosage / Q000627:therapeutic use; D002254:Carbonates / Q000008:administration & dosage / Q000627:therapeutic use; D002327:Cariostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003731:Dental Caries / Q000517:prevention & control*; D003802:Dentifrices / Q000008:administration & dosage / Q000627:therapeutic use*; D003807:Dentin Sensitivity / Q000517:prevention & control; D005898:Glass; D006801:Humans; D014077:Tooth Erosion / Q000517:prevention & control; D014089:Tooth Remineralization
D001031:Apatites; D002130:Calcium Phosphates; D002254:Carbonates; D002327:Cariostatic Agents; D003802:Dentifrices; C510984:NovaMin; C413465:hydroxycarbonate apatite